Skip to content

Clinical trials

Graves Ophthalmopathy trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Ophthalmopathy Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20132
20141
20211
20224
20233
20246
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Viridian Therapeutics, Inc.5
Amgen3
Immunovant Sciences GmbH2
argenx2
Cardiff University1
GlaxoSmithKline1
Hoffmann-La Roche1
Imperial College London1
Lassen Therapeutics Inc.1
Newcastle-upon-Tyne Hospitals NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Ophthalmopathy19
Graves Disease6
Eye Diseases3
Autoimmune Diseases2
Endocrine System Diseases2
Exophthalmos2
Orbital Diseases2
Thyroid Diseases2
Asthma1
Hashimoto Disease1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.